12
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Peripapillary Retinal Vascular Involvement in Early Post-COVID-19 Patients

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The ability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2′s) to cause multi-organ ischemia and coronavirus-induced posterior segment eye diseases in mammals gave concern about potential sight-threatening ischemia in post coronavirus disease 2019 patients. The radial peripapillary capillary plexus (RPCP) is a sensitive target due to the important role in the vascular supply of the peripapillary retinal nerve fiber layer (RNFL). Eighty patients one month after SARS-CoV-2 infection and 30 healthy patients were selected to undergo structural OCT (optical coherence tomography) and OCTA (optical coherence tomography angiography) exams. Primary outcome was a difference in RPCP perfusion density (RPCP-PD) and RPCP flow index (RPCP-FI). No significant difference was observed in age, sex, intraocular pressure (IOP) and prevalence of myopia. RPCP-PD was lower in post SARS-CoV-2 patients compared to controls. Within the post-COVID-19 group, patients with systemic arterial hypertension had lower RPCP-FI and age was inversely correlated to both RPCP-FI and RPCP-PD. Patients treated with lopinavir + ritonavir or antiplatelet therapy during admission had lower RPCP-FI and RPCP-PD. RNFL average thickness was linearly correlated to RPCP-FI and RPCP-PD within post-COVID-19 group. Future studies will be needed to address the hypothesis of a microvascular retinal impairment in individuals who recovered from SARS-CoV-2 infection.

          Related collections

          Most cited references43

          • Record: found
          • Abstract: found
          • Article: found

          Emerging coronaviruses: Genome structure, replication, and pathogenesis

          Abstract The recent emergence of a novel coronavirus (2019‐nCoV), which is causing an outbreak of unusual viral pneumonia in patients in Wuhan, a central city in China, is another warning of the risk of CoVs posed to public health. In this minireview, we provide a brief introduction of the general features of CoVs and describe diseases caused by different CoVs in humans and animals. This review will help understand the biology and potential risk of CoVs that exist in richness in wildlife such as bats.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis

            Highlights • Platelet count can discriminate between patients with severe and non-severe novel coronavirus disease 2019 (COVID-19) infections. • Patients who did not survive have a significantly lower platelet count than survivors. • Thrombocytopenia is associated with increased risk of severe disease. • A substantial decrease in platelet count should serve as clinical indicator of worsening illness in hospitalized patients with COVID-19.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Virology, Epidemiology, Pathogenesis, and Control of COVID-19

              The outbreak of emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) in China has been brought to global attention and declared a pandemic by the World Health Organization (WHO) on March 11, 2020. Scientific advancements since the pandemic of severe acute respiratory syndrome (SARS) in 2002~2003 and Middle East respiratory syndrome (MERS) in 2012 have accelerated our understanding of the epidemiology and pathogenesis of SARS-CoV-2 and the development of therapeutics to treat viral infection. As no specific therapeutics and vaccines are available for disease control, the epidemic of COVID-19 is posing a great threat for global public health. To provide a comprehensive summary to public health authorities and potential readers worldwide, we detail the present understanding of COVID-19 and introduce the current state of development of measures in this review.
                Bookmark

                Author and article information

                Journal
                J Clin Med
                J Clin Med
                jcm
                Journal of Clinical Medicine
                MDPI
                2077-0383
                08 September 2020
                September 2020
                : 9
                : 9
                : 2895
                Affiliations
                [1 ]Ophthalmology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00196 Rome, Italy; asavastano21@ 123456gmail.com (A.S.); emanuelecrincoli1@ 123456gmail.com (E.C.); gambini.gloria@ 123456gmail.com (G.G.); umbertodevico@ 123456gmail.com (U.D.V.); mgcozzupoli@ 123456gmail.com (G.M.C.); c.carola@ 123456live.it (C.C.); stanislao.rizzo@ 123456gmail.com (S.R.)
                [2 ]Department of Ophthalmology, Catholic University of “Sacro Cuore”, 00168 Rome, Italy
                [3 ]Department of Ophthalmology, Western Eye Hospital, Imperial College Healthcare NHS Trust, London NW1 5QH, UK; saad.younis@ 123456nhs.net
                [4 ]Neuroscience Institute, Consiglio Nazionale delle Ricerche, Istituto di Neuroscienze, 56124 Pisa, Italy
                Author notes
                [* ]Correspondence: mariacristina.savastano@ 123456gmail.com ; Tel.: +39-063-015-4928
                [†]

                These authors contributed equally to this work.

                Author information
                https://orcid.org/0000-0003-1575-6567
                https://orcid.org/0000-0001-9996-9871
                https://orcid.org/0000-0003-1397-4333
                https://orcid.org/0000-0001-8557-3964
                https://orcid.org/0000-0002-2803-5550
                https://orcid.org/0000-0003-3221-3791
                Article
                jcm-09-02895
                10.3390/jcm9092895
                7565672
                32911619
                76d7c82f-f1d8-4401-adb6-9caa7532087f
                © 2020 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 05 August 2020
                : 03 September 2020
                Categories
                Article

                oct angiography,peripapillary capillary perfusion,personalized medicine,sars-cov-2

                Comments

                Comment on this article